Antiplatelet therapy and risk of adverse cardiovascular events in peripheral artery disease

被引：0
|
作者：
Kamil, S. [1 ]
Sehested, T. S. G. [2 ]
Blanche, P. [3 ]
Houlind, K. [4 ]
Lassen, J. F. [5 ]
Gislasonl, G. [1 ]
Dorninguez, H. [6 ]
机构：
[1] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark
[2] Roskilde Univ Hosp, Cardiol, Roskilde, Denmark
[3] Univ Copenhagen, Publ Hlth & Biostat, Copenhagen, Denmark
[4] Lillebaelt Hosp, Dept Vasc Surg, Kolding, Denmark
[5] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[6] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2321 / 2321
页数：1
相关论文
共 50 条
  • [31] Type 2 Diabetes and Risk of Cardiovascular Events in Peripheral Artery Disease versus Coronary Artery Disease Patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2020, 142
  • [32] TYPE 2 DIABETES AND RISK OF CARDIOVASCULAR EVENTS IN PERIPHERAL ARTERY DISEASE VERSUS CORONARY ARTERY DISEASE PATIENTS
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Mutschlechner, B.
    Klement, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    ATHEROSCLEROSIS, 2021, 331 : E199 - E199
  • [33] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S354 - S354
  • [34] Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients
    Mackman, Nigel
    Spronk, Henri M. H.
    Stouffer, George A.
    ten Cate, Hugo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 726 - 732
  • [35] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
    Park, Byung Joon
    Hou, Linle
    Galmer, Andrew
    Johnston-Cox, Hillary
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (09) : 379 - 390
  • [36] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
    Byung Joon Park
    Linle Hou
    Andrew Galmer
    Hillary Johnston-Cox
    Current Treatment Options in Cardiovascular Medicine, 2023, 25 : 379 - 390
  • [37] Antiplatelet therapy in patient undergoing angioplasty for peripheral artery disease
    Kownator, Serge
    PRESSE MEDICALE, 2017, 46 (7-8): : 724 - 727
  • [38] Coronary Artery Disease and Major Adverse Cardiovascular Events in People With Hepatic Steatosis at Low Atherosclerotic Cardiovascular Disease Risk
    Karady, Julia
    Mayrhofer, Thomas
    Foldyna, Borek
    Lu, Michael T.
    Meyersohn, Nandini
    Hoffmann, Udo
    Balogon, Oluwafemi
    Pagidipati, Neha
    Shah, Svati
    Douglas, Pamela S.
    Ferencik, Maros
    Corey, Kathleen
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (03) : 558 - 569
  • [39] Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events
    Omiye, Jesutofunmi A.
    Ghanzouri, Ilies
    Lopez, Ivan
    Wang, Fudi
    Cabot, John
    Amal, Saeed
    Ye, Jianqin
    Lopez, Nicolas Gabriel
    Adebayo-Tijani, Faatihat
    Ross, Elsie Gyang
    PLOS ONE, 2024, 19 (05):
  • [40] Cardiovascular risk prevention in peripheral artery disease
    Hackam, DG
    JOURNAL OF VASCULAR SURGERY, 2005, 41 (06) : 1070 - 1073
12345